Giant Biogene Holding Co (HKSE:02367) Net Income Including Noncontrolling Interests : HK$1,584 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Giant Biogene Holding Co Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Giant Biogene Holding Co's Net Income Including Noncontrolling Interests for the six months ended in Dec. 2023 was HK$856 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,584 Mil.

Giant Biogene Holding Co Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Giant Biogene Holding Co's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Giant Biogene Holding Co Net Income Including Noncontrolling Interests Chart

Giant Biogene Holding Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income Including Noncontrolling Interests

640.03

979.74

1,014.02

1,118.49

1,584.01

Giant Biogene Holding Co Semi-Annual Data
	Dec19	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Net Income Including Noncontrolling Interests	Get a 7-Day Free Trial			-	512.54	630.21	728.48	855.53

Giant Biogene Holding Co Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$1,584 Mil.

Giant Biogene Holding Co Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Giant Biogene Holding Co's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Giant Biogene Holding Co (HKSE:02367) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Giant Biogene Holding Co Ltd (HKSE:02367) » Definitions » Net Income Including Noncontrolling Interests

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1855, Shanglin Yuan 7th Road, Chang’an District, Shaanxi Province, Xi’an, CHN

Website

http://www.xajuzi.com

Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.

Executives

Refulgence Holding Limited	2201 Interest of corporation controlled by you
Juzi Holding Co., Ltd	2101 Beneficial owner
Fan Daidi	2201 Interest of corporation controlled by you
Yan Jianya	2202 Interest of your spouse
Yi Fang Da Ji Jin Guan Li You Xian Gong Si	2102 Investment manager
Yan Jianya	2101 Beneficial owner
Fan Daidi
Trident Trust Company (b.v.i.) Limited	2301 Trustee

Giant Biogene Holding Co (HKSE:02367) Headlines

No Headlines